Advancing Homologous Recombination Based Genome Editing of Hematopoietic Stem Cells
Matthew Porteus - Sutardja Chuk Professor of Definitive & Curative Medicine
Bio-X Affiliated Faculty
One of the primary interests of the Porteus lab group is to develop homologous recombination as a method of gene therapy for genetic diseases.
Research News
Researchers take step toward gene therapy for sickle cell disease
November 7, 2016 - Stanford Medicine News Center
Using the CRISPR gene-editing technique in stem cells, Bio-X affiliates Matthew Porteus, Kenneth...
Porteus receives $1M stem cell grant for ‘bubble boy disease’
March 26, 2015 - Stanford Medicine News Center
The grant, awarded to Bio-X affiliated faculty member Matthew Porteus, will allow the researcher to...
New way of genome editing could cure hemophilia in mice; may be safer than older method, study shows
October 29, 2014 - Stanford Medicine News Center
A technique developed under Bio-X affiliated faculty members Mark Kay and Matthew Porteus could...